Medigene AG
MDG1
Clasificación en acciones
#35302
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Precio por acción
$0.14942078
Última sincronización: 2025-05-15
Capitalización bursátil
$3.86M
Cambio (1 día)
0.10%
Cambio (1 año)
47.84%
País
DE
Comercio Medigene AG (MDG1)
Categoría
Healthcare
Historial de desdoblamientos de acciones de Medigene AG (MDG1)
La acción Medigene AG (símbolo: MDG1) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Oct 21, 2026.
Una acción MDG1 comprada antes de Oct 21, 2026 equivaldría hoy a 0 acciones MDG1.
El desdoblamiento más reciente ocurrió el Oct 21, 2026.
Una acción MDG1 comprada antes de Oct 21, 2026 equivaldría hoy a 0 acciones MDG1.
Lista de desdoblamientos de acciones
| Año | Desdoblamiento | Multiplicador | Multiplicador acumulado |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Desdoblamientos de acciones de empresas similares o competidoras
| Empresa | Número de desdoblamientos de acciones | Multiplicador acumulado | País |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
